Y0002255

システム適合性用スリンダク

European Pharmacopoeia (EP) Reference Standard

• 別名: スリンダク, (Z)-5-フルオロ-2-メチル-1-[p-(メチルスルフィニル)ベンジリデン]インデン-3-酢酸
• 実験式（ヒル表記法）: C₂₀H₁₇FO₃S
• CAS番号: 38194-50-2
• 分子量: 356.41
• MDL番号: MFCD00599589
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• APIファミリー: sulindac
• メーカー／製品名: EDQM
• 保管温度: 2-8°C
• SMILES記法: CC1=C(CC(O)=O)c2cc(F)ccc2\C1=C/c3ccc(cc3)S(C)=O
• InChI: 1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-
• InChI Key: MLKXDPUZXIRXEP-MFOYZWKCSA-N

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Sulindac for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

生物化学的／生理学的作用

非ステロイド系抗炎症薬であり、COX-1の選択的インヒビタ-です。

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS06,GHS08
• シグナルワード: Danger
• 危険有害性情報: H301,H317,H334,H361
• 注意書き: P201 - P202 - P280 - P301 + P310 - P302 + P352 - P304 + P340 + P312
• 危険有害性の分類: Acute Tox. 3 Oral - Repr. 2 - Resp. Sens. 1 - Skin Sens. 1
• 保管分類コード: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable